People with ulcerative colitis (UC) or adenomatous polyps (adenomas) are at increased risk of colorectal cancer (CRC) (1) . Altered expression of microRNAs (miRNAs), small non-coding RNAs that regulate gene expression post-transcriptionally, has been observed in those with UC (2) and adenomas (3) . Importantly, abnormally-expressed miRNAs contribute to the initiation and progression of CRC and are potential biomarkers for diagnosis and prognosis of this cancer (4) . This study aimed to investigate differences in the expression of a panel of miRNAs in the macroscopically-normal mucosa of people at higher-risk of CRC.
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We quantified expression of 8 miRNAs that are (i) implicated in CRC, (ii) regulators of WNT signalling, a pathway frequently aberrantly activated in CRC (5) , and/or (iii) whose expression is altered by butyrate treatment in healthy participants (n = 56) and in patients at higher CRC risk with quiescent UC (n = 26) or history of adenomatous polyps (n = 12). RNA was isolated from mucosal biopsies of macroscopically-normal tissue collected at 10 cm from the anal verge. cDNA was synthesised by reverse transcription and used to quantify the expression of miR-17, miR-19a, miR-19b, miR-20a, miR-25, miR-93, miR-106b and miR-424 by quantitative PCR. For normally distributed data, the ANOVA General Linear Model was used to compare miRNA expression between the 3 risk groups, adjusting for age, sex and endoscopy procedure as covariates. Where data were not normally distributed, the nonparametric Kruskal-Wallis test was used.
We observed significantly higher miR-424 expression (p < 0·01), a miRNA reported to be increased in CRCs (6) , and reduced miR-20a expression (p = 0·055) in participants with quiescent UC (Table 1) . miR-20a expression also appears to be reduced in polyp patients. Alterations in miRNA expression may be detected in the healthy tissue of people at higher-risk of CRC and may represent very early molecular changes contributing to the progression from normal mucosa to carcinoma. 
